Coskun Receives $1.86 Million NIH MIRA Award to Map Spatial Molecular Neighborhoods

Ahmet Coskun has a saying on the homepage of his  lab’s website : “Seeing is believing. Quantifying is proving.” So, with that in mind, Coskun and his team have developed multiplex imaging tools and combined them with machine learning techniques – for believing and quantifying.  

Now, to support Coskun’s research, the National Institutes of Health has granted him the prestigious  Maximizing Investigator’s Research Award  (MIRA) from the National Institute of General Medical Sciences. Coskun and his team will use the five-year, $1.86 million award for a project entitled,  “Dissecting subcellular and cellular organization by spatial molecular neighborhood networks.”  

They plan to probe subcellular and cellular organization, counting molecular neighborhoods and building maps to help researchers better understand the spatial organization of cells and molecules, insights that can open the door to game-changing personalized treatments for multiple diseases. 

“The spatial organization of these neighborhoods, of RNA and protein molecules, is important for cellular function,” said Coskun, a Bernie Marcus Early Career Professor in the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. “So, we’re basically making maps of molecules within the cell.” 

The maps can ultimately help researchers identify cell types that would best treat various diseases, while also explaining why some patients will respond to a particular treatment, and others won’t. 

The NIH’s MIRA program provides researchers with greater stability and flexibility in funding while enhancing their ability to creatively tackle ambitious scientific problems. And part of the aim, said Coskun, “is to address basic biology questions that have implications on multiple diseases in the future. This single cell work has that kind of potential.” 

For Coskun, the MIRA is the next phase of support in a flurry of awards that have come his way recently: it’s the fifth NIH grant his lab has received this year, with a total value of $3.6 million. 

“This year has been a great year for us,” said Coskun. “It’s encouraging to receive this kind of recognition and support for research and technology that we believe will play an important role in the lives of patients.”  

Contact

Jerry Grillo
Communications
Wallace H. Coulter Department of Biomedical Engineering

By Maria Thacker Goethe October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape
October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.
October 1, 2025
September 30, 2025 WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, Americans have subsidized the research and development necessary to bring newer and better medicines to patients around the world. As we saw with defense spending and NATO, the solution is not to weaken a strategically important American industry, but for other countries to pay their fair share. “Today’s announcement in the Oval Office highlights the problems with a drug delivery system where half of the cost of innovative medicines goes to middlemen and distributors, and where the supply chain distorts prices paid by the American people. We support a new framework that addresses the cost of medicines by simplifying the system - and making medicines directly available to patients. “But importing socialist price controls through most-favored nation policies fundamentally does not address the imbalance in international pricing for innovative medicines. MFN will not lower the out-of-pocket prices that most Americans pay for medicines. Even worse, it will jeopardize the entrepreneurial spirit and deter the capital necessary for a vibrant and essential American biotechnology industry to thrive and may cause most harm to small and midsize biotech companies, which are responsible for discovering more than half of all new treatments. “Without these biotech innovators and a free-market system, we risk slower scientific progress, decreased access to new medicines, compromised national security, fewer American jobs and perhaps most tragically, a diminished hope for those suffering with illness and disease. There are much better ways to address this problem than MFN.” ###
MORE POSTS